Received: 19 January 2018
Accepted: 21 August 2018
First Online: 31 August 2018
: The study was conducted in accordance with guidelines for Good Clinical Practice (VICH GL9). The protocol was reviewed and approved by Novartis Animal Health Inc.’s (acquired by Elanco Animal Health, a division of Eli Lilly and Company) Institutional Animal Care and Use Committee. All owners provided written consent upon their dog entering the study (Day 0).
: Not applicable
: All authors are employees of Elanco Animal Health, a Division of Eli Lilly and Company.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.